Home
About BHIVA
Contact us
Sitemap
Members Login
Join BHIVA
Committees
Governance
Membership
Annual Report and Accounts
You are here: >
Clinical Guidelines
>
Current Guidelines
>
TB/HIV Infection (2005)
>
17.0 Tables
My Account
Audit and Clinical Standards
Summary
National Audit Schedule
National Audit Reports
Clinical Standards
Conferences and Events
Summary
Forthcoming Conferences
BHIVA 'Best of CROI' Feedback Meetings
18th Annual Conference of the British HIV Association (BHIVA)
5th Annual BHIVA Conference for the Management of HIV / Hepatitis Co-infection
BHIVA Autumn Conference 2012
Previous Conferences
2012
2011
2010
2009
2008
Conference Abstracts
HIV Event Diary
National Events
International Events
Regional Meetings
Clinical Guidelines
Summary
Current Guidelines
Archived Guidelines
Education and Research
Summary
Diploma in HIV Medicine
E-Learning
Research Awards
BHIVA Research Award
Gilead SpR Research Award
Fundraising
Summary
Donate to BHIVA
2011 Virgin London Marathon
HIV Medicine Journal
Links
Summary
Clinical Practice
Professional Associations
NGOs (Community)
Educational
Public Health and International
Governmental
Research
Publications
Scholarships and Awards
Summary
Conference Awards
Conference Scholarships
BHIVA Research Award
Search in:
All Site
Audit and clinical standards
Other publications
Clinical guidelines
Submit
17.0 Tables
Print
Email
Read the treatment guidelines online - Summary
1.0 Introduction
2.0 Aims of TB treatment
3.0 Laboratory diagnosis
4.0 Type and duration of TB treatment
5.0 Drug/drug interactions (see Table 1 & 2)
6.0 Overlapping toxicity profiles of antiretroviral drugs with anti-tuberculosis therapy
7.0 Drug absorption
8.0 When to start HAART
9.0 Directly observed therapy (DOT)
10.0 Tuberculin skin testing
11.0 Chemo preventative therapy – HAART or antituberculosis drugs?
12.0 Management of relapse, treatment failure and drug resistance
13.0 Pregnancy and breastfeeding
14.0 Immune reconstitution inflammatory syndrome (IRIS) / paradoxical reactions
15.0 Prevention and control of transmission of HIV related tuberculosis
16.0 Death and clinico-pathological audit of HIV-associated tuberculosis
17.0 Tables
18.0 References
Please see the documents to the right for the tables used in these guidelines.